New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Lung cancer rates vary by subtype and adenocarcinoma incidence worldwide, likely due to differences in air pollution, smoking, and generational patterns.

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

The CDC says in the U.S. about 10 to 20 percent of lung cancers are found in non-smokers. That also includes people smoking ...

In a new study that challenges long-held views on lung cancer, University of Kentucky Markey Cancer Center researchers have discovered a surprising ...

An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

Research assessing the nutritional status and impact of interventions for patients with lung cancer found that most exhibit ...